Search for: "Lowe v. Medtronic, Inc." Results 21 - 40 of 51
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Apr 2014, 5:00 am
Medtronic, Inc., 704 F.3d 1224 (9th Cir. 2013). [read post]
8 May 2009, 5:01 am
Medtronic, Inc., 128 S.Ct. 999 (2008), holding that the preemption clause of the Medical Device Amendments of 1976 (21 U.S.C. [read post]
13 Oct 2008, 12:12 pm
ECJ clarifies rules relating to notice: K-Swiss Inc v OHIM (Class 46) EU Competitiveness Council resolution against counterfeiting and piracy (Class 46) EU states back three-point anti-piracy plan (Managing Intellectual Property) Fuel cells and wind power lead European patent filings for clean energy technology (Green Patent Blog) More non-minor geographical indicator (GI) amendments published (Class 46) No sign of any Community patent progress, despite Verheugen's optimism… [read post]
17 Feb 2016, 4:30 am
Medtronic, Inc., 552 U.S. 312 (2008), where he held that most tort claims against PMA devices are expressly preempted by a federal statute. [read post]
4 Sep 2008, 11:49 am
Medtronic, Inc., 128 S.Ct. 999, 1008 (2008). [read post]
19 Jul 2007, 1:47 pm
Medtronic, Inc., 750 F.2d 1227, 1233 n.13 (4th Cir. 1984) (applying South Carolina law); Adamson v. [read post]
26 Feb 2013, 11:37 am by Michelle Yeary
Medtronic, Inc., 552 U.S. 312 (2008) (state law claims that impose requirements “different from or in addition to” FDA’s PMA requirements are preempted). [read post]
1 May 2008, 11:21 am
Beretta USA, Inc., No. 05-6942-cv (2d Cir. [read post]
23 Aug 2008, 1:23 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) CAFC decides Apotex and Impax infringed AstraZeneca’s Prilosec patents: (Law360), (Patent Prospector), (Patent Docs), (GenericsWeb), CAFC upholds lower court’s decision finding USPTO was within its rights to subject a Cooper patent to… [read post]
Since President Biden issued his July 2021 Executive Order on Competition, the antitrust agencies have made broad policy statements promising more aggressive enforcement and have initiated a number of high-profile enforcement actions. [read post]